Literature DB >> 369690

Combination 6-mercaptopurine and 6-methylmercaptopurine riboside in the treatment of adult acute leukemia: a Southwest Oncology Group study.

J S Hewlett, G P Bodey, H E Wilson, W J Stuckey.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 369690

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN： 0361-5960


× No keyword cloud information.
  3 in total

1.  Phase I trial of the combination of 6-methylmercaptopurine riboside and 5-fluorouracil.

Authors:  M C Wiemann; G W Crabtree; A B Weitberg; E N Spremulli; F J Cummings; C Murray; P Calabresi
Journal:  Med Oncol Tumor Pharmacother       Date:  1988

2.  A thiopurine drug inhibits West Nile virus production in cell culture, but not in mice.

Authors:  Pei-Yin Lim; Julie A Keating; Spencer Hoover; Rob Striker; Kristen A Bernard
Journal:  PLoS One       Date:  2011-10-24       Impact factor: 3.240

Review 3.  Mercaptopurine/Methotrexate maintenance therapy of childhood acute lymphoblastic leukemia: clinical facts and fiction.

Authors:  Kjeld Schmiegelow; Stine N Nielsen; Thomas L Frandsen; Jacob Nersting
Journal:  J Pediatr Hematol Oncol       Date:  2014-10       Impact factor: 1.289
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.